As of Jul 01
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 3.65, with a high estimate of 3.65 and a low estimate of 3.65. The median estimate represents a +174.34% increase from the last price of 1.33.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.